Serum gets notice for continuing vaccine trials

Serum gets notice for continuing vaccine trials Sushmi Dey, Umesh Isalkar & Rupali Mukherjee India’s central drug regulator Wednesday issued a notice to Pune-based Serum Institute of India (SII), asking why the firm hadn’t informed it about the “reported serious adverse events” that led its UK partner AstraZeneca to “temporarily pause” global https://ift.tt/eA8V8J